TITLE

Recombinant Full-Length Parathyroid Hormone (1-84)

AUTHOR(S)
Moen, Marit D.; Scott, Lesley J
PUB. DATE
May 2007
SOURCE
BioDrugs;2007, Vol. 21 Issue 3, p205
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the importance of recombinant full-length parathyroid hormone in treating osteoporosis. Osteoporosis occurs when the rate of bone resorption exceeds the rate of bone formation. The resulting loss of bone mass and strength can lead to fragility fractures. Available treatments for postmenopausal osteoporosis include agents that inhibit bone resorption such as bisphosphonates. Synthetic versions of endogenous parathyroid hormone have been shown to increase new bone formation.
ACCESSION #
25495151

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics